Logo image of MNST

MONSTER BEVERAGE CORP (MNST) Stock Fundamental Analysis

NASDAQ:MNST - Nasdaq - US61174X1090 - Common Stock - Currency: USD

55.265  +0.62 (+1.13%)

Fundamental Rating

6

Overall MNST gets a fundamental rating of 6 out of 10. We evaluated MNST against 32 industry peers in the Beverages industry. MNST scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MNST is quite expensive at the moment. It does show a decent growth rate. This makes MNST very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MNST had positive earnings in the past year.
MNST had a positive operating cash flow in the past year.
Each year in the past 5 years MNST has been profitable.
Of the past 5 years MNST 4 years had a positive operating cash flow.
MNST Yearly Net Income VS EBIT VS OCF VS FCFMNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

MNST has a Return On Assets of 19.93%. This is amongst the best in the industry. MNST outperforms 96.55% of its industry peers.
The Return On Equity of MNST (27.78%) is better than 82.76% of its industry peers.
MNST has a better Return On Invested Capital (22.53%) than 93.10% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MNST is significantly above the industry average of 13.30%.
The last Return On Invested Capital (22.53%) for MNST is above the 3 year average (19.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 19.93%
ROE 27.78%
ROIC 22.53%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.15%
ROIC(5y)20.23%
MNST Yearly ROA, ROE, ROICMNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 21.66%, MNST belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.
In the last couple of years the Profit Margin of MNST has declined.
MNST has a Operating Margin of 26.76%. This is amongst the best in the industry. MNST outperforms 82.76% of its industry peers.
MNST's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 53.77%, MNST is doing good in the industry, outperforming 65.52% of the companies in the same industry.
In the last couple of years the Gross Margin of MNST has declined.
Industry RankSector Rank
OM 26.76%
PM (TTM) 21.66%
GM 53.77%
OM growth 3Y-7.48%
OM growth 5Y-5.21%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
MNST Yearly Profit, Operating, Gross MarginsMNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

MNST has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MNST has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MNST has been reduced compared to 5 years ago.
The debt/assets ratio for MNST is higher compared to a year ago.
MNST Yearly Shares OutstandingMNST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MNST Yearly Total Debt VS Total AssetsMNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 17.40 indicates that MNST is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 17.40, MNST belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
The Debt to FCF ratio of MNST is 0.46, which is an excellent value as it means it would take MNST, only 0.46 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.46, MNST belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
MNST has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
MNST has a better Debt to Equity ratio (0.13) than 79.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.46
Altman-Z 17.4
ROIC/WACC2.52
WACC8.93%
MNST Yearly LT Debt VS Equity VS FCFMNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 3.13 indicates that MNST has no problem at all paying its short term obligations.
MNST has a Current ratio of 3.13. This is amongst the best in the industry. MNST outperforms 89.66% of its industry peers.
MNST has a Quick Ratio of 2.51. This indicates that MNST is financially healthy and has no problem in meeting its short term obligations.
MNST's Quick ratio of 2.51 is amongst the best of the industry. MNST outperforms 96.55% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 2.51
MNST Yearly Current Assets VS Current LiabilitesMNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.21% over the past year.
Measured over the past years, MNST shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.72% on average per year.
Looking at the last year, MNST shows a small growth in Revenue. The Revenue has grown by 4.94% in the last year.
MNST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.27% yearly.
EPS 1Y (TTM)3.21%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%0%
Revenue 1Y (TTM)4.94%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%4.74%

3.2 Future

MNST is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.86% yearly.
Based on estimates for the next years, MNST will show a quite strong growth in Revenue. The Revenue will grow by 8.80% on average per year.
EPS Next Y17.05%
EPS Next 2Y14.14%
EPS Next 3Y16.33%
EPS Next 5Y13.86%
Revenue Next Year6.99%
Revenue Next 2Y8.03%
Revenue Next 3Y8.81%
Revenue Next 5Y8.8%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MNST Yearly Revenue VS EstimatesMNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
MNST Yearly EPS VS EstimatesMNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 34.33, which means the current valuation is very expensive for MNST.
62.07% of the companies in the same industry are cheaper than MNST, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of MNST to the average of the S&P500 Index (29.98), we can say MNST is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 29.33, the valuation of MNST can be described as expensive.
Based on the Price/Forward Earnings ratio, MNST is valued a bit more expensive than 65.52% of the companies in the same industry.
MNST is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.66, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 34.33
Fwd PE 29.33
MNST Price Earnings VS Forward Price EarningsMNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MNST is valued a bit more expensive than 72.41% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as MNST.
Industry RankSector Rank
P/FCF 33.23
EV/EBITDA 25.36
MNST Per share dataMNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MNST does not grow enough to justify the current Price/Earnings ratio.
MNST has an outstanding profitability rating, which may justify a higher PE ratio.
MNST's earnings are expected to grow with 16.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.01
PEG (5Y)N/A
EPS Next 2Y14.14%
EPS Next 3Y16.33%

0

5. Dividend

5.1 Amount

MNST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MONSTER BEVERAGE CORP

NASDAQ:MNST (3/3/2025, 2:12:09 PM)

55.265

+0.62 (+1.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners68.51%
Inst Owner Change0.65%
Ins Owners0.41%
Ins Owner Change16.95%
Market Cap53.75B
Analysts73.94
Price Target56.51 (2.25%)
Short Float %3.05%
Short Ratio3.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.86%
Min EPS beat(2)-11.44%
Max EPS beat(2)-8.27%
EPS beat(4)0
Avg EPS beat(4)-6.83%
Min EPS beat(4)-11.44%
Max EPS beat(4)-2.77%
EPS beat(8)2
Avg EPS beat(8)-3.71%
EPS beat(12)2
Avg EPS beat(12)-6.01%
EPS beat(16)3
Avg EPS beat(16)-4.89%
Revenue beat(2)0
Avg Revenue beat(2)-5.45%
Min Revenue beat(2)-7.47%
Max Revenue beat(2)-3.44%
Revenue beat(4)0
Avg Revenue beat(4)-4.08%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)-2.06%
Revenue beat(8)0
Avg Revenue beat(8)-3.82%
Revenue beat(12)3
Avg Revenue beat(12)-1.99%
Revenue beat(16)5
Avg Revenue beat(16)-1.18%
PT rev (1m)0.18%
PT rev (3m)0.05%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)0.27%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)1.1%
Revenue NQ rev (1m)-0.22%
Revenue NQ rev (3m)-0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 34.33
Fwd PE 29.33
P/S 7.25
P/FCF 33.23
P/OCF 28.27
P/B 9.3
P/tB 18.41
EV/EBITDA 25.36
EPS(TTM)1.61
EY2.91%
EPS(NY)1.88
Fwd EY3.41%
FCF(TTM)1.66
FCFY3.01%
OCF(TTM)1.95
OCFY3.54%
SpS7.62
BVpS5.94
TBVpS3
PEG (NY)2.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.93%
ROE 27.78%
ROCE 29.13%
ROIC 22.53%
ROICexc 29.6%
ROICexgc 66.05%
OM 26.76%
PM (TTM) 21.66%
GM 53.77%
FCFM 21.82%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.15%
ROIC(5y)20.23%
ROICexc(3y)28.38%
ROICexc(5y)31.93%
ROICexgc(3y)63.04%
ROICexgc(5y)83.74%
ROCE(3y)24.76%
ROCE(5y)26.15%
ROICexcg growth 3Y-14.66%
ROICexcg growth 5Y-14.71%
ROICexc growth 3Y-7.48%
ROICexc growth 5Y-3.26%
OM growth 3Y-7.48%
OM growth 5Y-5.21%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 0.46
Debt/EBITDA 0.36
Cap/Depr 362.45%
Cap/Sales 3.83%
Interest Coverage 142.49
Cash Conversion 92.23%
Profit Quality 100.74%
Current Ratio 3.13
Quick Ratio 2.51
Altman-Z 17.4
F-Score7
WACC8.93%
ROIC/WACC2.52
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.21%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%0%
EPS Next Y17.05%
EPS Next 2Y14.14%
EPS Next 3Y16.33%
EPS Next 5Y13.86%
Revenue 1Y (TTM)4.94%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%4.74%
Revenue Next Year6.99%
Revenue Next 2Y8.03%
Revenue Next 3Y8.81%
Revenue Next 5Y8.8%
EBIT growth 1Y3.62%
EBIT growth 3Y2.3%
EBIT growth 5Y6.42%
EBIT Next Year15.41%
EBIT Next 3Y13.76%
EBIT Next 5Y11.53%
FCF growth 1Y13.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y20.18%
OCF growth 3YN/A
OCF growth 5YN/A